Grand Pharmaceutical Group Limited Is A Research Based International Pharmaceutical Enterprise Headquartered In Hong Konglisted On The Hong Kong Stock Exchangethe Company Focuses On The Manufacturing And Sales Of Pharmaceutical Preparationsmedical Devicesbiotechnology Productsnutrition Productsand Specialized Pharmaceutical Raw Materialsestablished In 1995Grand Pharma Has Grown Significantlygoing Public In 2008 And Expanding Through Strategic Mergers And Acquisitions The Company Offers A Diverse Range Of Products Across Several Therapeutic Areasincluding Anti Tumor And Cardiovascular Productsadvanced Medical Devicesand Innovative Mrna And Glycomics Technologiesgrand Pharma Operates R&D Centers In Chinathe United Statesand Australiaemphasizing Innovation And Global Expansionthe Company Collaborates With Partners Like Etherna To Enhance Its Mrna Development Capabilitieswith A Reported Revenue Of Hkd 11 64 Billion And A Net Income Of Hkd 2 47 Billiongrand Pharmaceutical Group Employs Around 11 990 Peopledelivering Advanced Healthcare Solutions To Healthcare Providers And Patients
